India Business Excellence Fund III Trims Stake in Molbio Diagnostics
Molbio Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 01 Oct 2026, 3:50 pm
India Business Excellence Fund III Trims Stake in Molbio Diagnostics India Business Excellence Fund III, managed by MO Alternate Investment Advisors, sold 23,77,627 equity shares (2.06% stake) of Molbio Diagnostics Ltd via the open market on 30th Sep'26. Following this disposal, the fund's shareholding in the company decreased from 1,02,76,750 equity shares (8.92% of total voting capital) to 78,99,123 equity shares (6.85%). The transaction breached the 2% threshold under Regulation 29(2) of SEBI SAST Regulations, triggering the statutory disclosure. Total voting capital post-transaction remains unchanged at 11,52,39,996 equity shares.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company 路 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
